Cargando…
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer’s Disease
[Image: see text] With innumerable clinical failures of target-specific drug candidates for multifactorial diseases, such as Alzheimer’s disease (AD), which remains inefficiently treated, the advent of multitarget drug discovery has brought a new breath of hope. Here, we disclose a class of 6-chloro...
Autores principales: | Codony, Sandra, Pont, Caterina, Griñán-Ferré, Christian, Di Pede-Mattatelli, Ania, Calvó-Tusell, Carla, Feixas, Ferran, Osuna, Sílvia, Jarné-Ferrer, Júlia, Naldi, Marina, Bartolini, Manuela, Loza, María Isabel, Brea, José, Pérez, Belén, Bartra, Clara, Sanfeliu, Coral, Juárez-Jiménez, Jordi, Morisseau, Christophe, Hammock, Bruce D., Pallàs, Mercè, Vázquez, Santiago, Muñoz-Torrero, Diego |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958510/ https://www.ncbi.nlm.nih.gov/pubmed/35271276 http://dx.doi.org/10.1021/acs.jmedchem.1c02150 |
Ejemplares similares
-
From the Design
to the In Vivo Evaluation
of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors
for the Treatment of Acute Pancreatitis
por: Codony, Sandra, et al.
Publicado: (2021) -
2-(Piperidin-4-yl)acetamides as Potent Inhibitors of Soluble Epoxide Hydrolase with Anti-Inflammatory Activity
por: Martín-López, Juan, et al.
Publicado: (2021) -
Synthesis, In Vitro
Profiling, and In Vivo Evaluation
of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication
for Soluble Epoxide Hydrolase Inhibitors
por: Codony, Sandra, et al.
Publicado: (2022) -
A Combined Chronic Low-Dose Soluble Epoxide Hydrolase and Acetylcholinesterase Pharmacological Inhibition Promotes Memory Reinstatement in Alzheimer’s Disease Mice Models
por: Jarne-Ferrer, Júlia, et al.
Publicado: (2022) -
Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson’s Disease: A New Therapeutic Strategy
por: Pallàs, Mercè, et al.
Publicado: (2020)